Figure 5. Immunostaining for intraocular
bevacizumab. No staining was detected using Anti-human antibody labeled
with CY3 dye in an untreated mouse after chemical burn injury (A)
without bevacizumab injection. Bevacizumab staining identified in the
anterior chamber, filtrating into the cornea, following intraocular
injection one day after injury (B).